Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26491. Epub 2017 Feb 24.

¹ Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
² Clinical Research Center, Nagoya Medical Center, National Hospital Organization, Nagoya, Japan.
³ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
⁴ Department of Pediatrics, National Hospital Organization, Fukuoka-Higashi Medical Center, Fukuoka, Japan.
⁵ Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan.
⁶ Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
⁷ Department of Pediatrics, Okayama University, Okayama, Japan.
⁸ Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
⁹ Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan.
¹⁰ Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan.
¹¹ Division of Leukemia and Lymphoma, National Center for Child Health and Development, Children's Cancer Center, Tokyo, Japan.
¹² Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
¹³ Division of Hemato-Oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
¹⁴ Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan.
¹⁵ Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.
¹⁶ Department of Human Health Sciences, Kyoto University, Kyoto, Japan.

No abstract available

Publication types